| 000 | 01795 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518023821.0 | ||
| 264 | 0 | _c20200618 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1878-5883 | ||
| 024 | 7 |
_a10.1016/j.jns.2019.01.047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChao, A-Ching | |
| 245 | 0 | 0 |
_aLow-dose versus standard-dose intravenous alteplase for octogenerian acute ischemic stroke patients: A multicenter prospective cohort study. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cApr 2019 |
||
| 300 |
_a76-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBrain Ischemia _xdiagnosis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aStroke _xdiagnosis |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHan, Ke | |
| 700 | 1 | _aLin, Sheng-Feng | |
| 700 | 1 | _aLin, Ruey-Tay | |
| 700 | 1 | _aChen, Chih-Hung | |
| 700 | 1 | _aChan, Lung | |
| 700 | 1 | _aLin, Huey-Juan | |
| 700 | 1 | _aSun, Yu | |
| 700 | 1 | _aLin, Yung-Yang | |
| 700 | 1 | _aChen, Po-Lin | |
| 700 | 1 | _aLin, Shinn-Kuang | |
| 700 | 1 | _aWei, Cheng-Yu | |
| 700 | 1 | _aLin, Yu-Te | |
| 700 | 1 | _aLee, Jiunn-Tay | |
| 700 | 1 | _aHu, Han-Hwa | |
| 700 | 1 | _aBai, Chyi-Huey | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 399 _gp. 76-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jns.2019.01.047 _zAvailable from publisher's website |
| 999 |
_c29388246 _d29388246 |
||